Dr. Sujith Kumar Mullapally

Dr. Sujith Kumar Mullapally is a Consultant in Medical Oncology at Apollo Proton Cancer Centre in Chennai, bringing over 9 years of dedicated clinical experience in comprehensive cancer care. He holds strong academic credentials including an MBBS, MD in Radiotherapy from All India Institute of Medical Sciences (AIIMS) New Delhi, and a DM in Medical Oncology from Tata Memorial Hospital under the Homi Bhabha National Institute in Mumbai. His training at these premier institutions has positioned him as a well-rounded physician with deep expertise in systemic oncology.

Dr. Mullapally specializes in a broad range of modern cancer therapies, including chemotherapy for solid tumors, immunotherapy with immune checkpoint inhibitors, molecular targeted therapy, and biomarker-based personalized treatment approaches. He is skilled in administering adjuvant and neoadjuvant chemotherapy protocols, hormone therapy for breast and prostate cancers, and low-dose metronomic chemotherapy regimens. His clinical depth is reflected in his commitment to evidence-based medicine and adoption of the latest research findings in his practice.

He has earned recognition for his clinical contributions, including the M. Jagadeesan Award for Young Radiation Oncology, which underscores his standing as a rising leader in oncology. Prior to his current role, Dr. Mullapally served as Head of the Oncology Department at Aster MIMS in Kannur, Kerala, and as a Specialist Registrar at Tata Memorial Centre in Mumbai—one of Asia's most respected comprehensive cancer centers. He welcomes international patients from the Gulf, South Asia, and Africa, and brings a patient-centered approach to complex oncology cases.

Apollo Proton Cancer Centre is equipped with advanced radiation and systemic therapy facilities, making it an ideal destination for comprehensive cancer treatment. The centre combines cutting-edge technology with experienced multidisciplinary teams, offering seamless care coordination for both local and international patients. International patients choosing treatment at Apollo benefit from streamlined admissions, translator support, and dedicated patient care coordinators. Dr. Mullapally's fluency in English, Hindi, and Tamil ensures clear communication and personalized care planning for patients from diverse backgrounds.